byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - augnlækningar - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - augnlækningar - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
torphasol vet (morphasol) stungulyf, lausn 10 mg/ml
animedica gmbh* - butorphanolum tartrat - stungulyf, lausn - 10 mg/ml
synarela nefúði, lausn 2 mg/ml
pfizer aps - nafarelinum acetat - nefúði, lausn - 2 mg/ml
jetrea
inceptua ab - ocriplasmin - sjúkdómar í sjónhimnu - augnlækningar - jetrea er ætlað fullorðnum til meðferðar á vöðvakvilla (vmt), þar á meðal þegar það er tengt macular holu með þvermál sem er minna en eða jafnt 400 míkron.
kabiven innrennslislyf, fleyti
fresenius kabi ab - soya-bean oil refined; glucosum; alaninum inn; arginine; aspartic acid; glutamic acid; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum inn; methioninum inn; phenylalaninum inn; proline; serine; threoninum inn; tryptophanum inn; tyrosinum inn; valine; natrii glycerophosphas; magnesii sulfas; kalii chloridum; sodium acetate trihydrate; calcium chloride dihydrate - innrennslislyf, fleyti
kabiven perifer innrennslislyf, fleyti
fresenius kabi ab - soya-bean oil refined; glucosum; alaninum inn; arginine; aspartic acid; glutamic acid; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum inn; methioninum inn; phenylalaninum inn; proline; serine; threoninum inn; tryptophanum inn; tyrosinum inn; valine; magnesii sulfas; kalii chloridum; sodium acetate trihydrate; natrii glycerophosphas; calcium chloride dihydrate - innrennslislyf, fleyti
sixmo
l. molteni & c. dei fratelli alitti società di esercizio s.p.a. - búprenorfín stutt og long-term - Ópíóíð-tengdir sjúkdómar - Önnur lyf í taugakerfinu - sixmo er ætlað fyrir skipta meðferð fyrir lifur fíkn í vísindalega stöðugt fullorðinn sjúklingum sem þurfa ekki meira en 8 mg/dag á tungu búprenorfín, innan ramma læknis, félagslegar og sálfræðileg meðferð.
sugammadex mylan
mylan ireland limited - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.